Protara Therapeutics Inc [TARA] stock is trading at $4.92, up 9.33%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TARA shares have gain 8.61% over the last week, with a monthly amount drifted -6.82%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, H.C. Wainwright started tracking the stock with Buy rating on June 04, 2021, and set its price target to $40. On February 17, 2021, Oppenheimer initiated with a Outperform rating and assigned a price target of $43 on the stock. Cowen started tracking the stock assigning a Outperform rating and suggested a price target of $50 on October 19, 2020. Guggenheim initiated its recommendation with a Buy and recommended $50 as its price target on July 29, 2020.
Protara Therapeutics Inc [TARA] stock has fluctuated between $1.60 and $10.48 over the past year. Protara Therapeutics Inc [NASDAQ: TARA] shares were valued at $4.92 at the most recent close of the market.
Analyzing the TARA fundamentals
Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -37.98%, Pretax Profit Margin comes in at -34.81%, and Net Profit Margin reading is -34.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.45, Equity is -0.56 and Total Capital is -0.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.54 points at the first support level, and at 4.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.15, and for the 2nd resistance point, it is at 5.38.
Ratios To Look Out For
For context, Protara Therapeutics Inc’s Current Ratio is 9.85. In addition, the Quick Ratio stands at 9.85 and the Cash Ratio stands at 5.99.
Transactions by insiders
Recent insider trading involved Opaleye Management Inc., 10% Owner, that happened on Sep 12 ’24 when 0.13 million shares were sold. 10% Owner, Opaleye Management Inc. completed a deal on Sep 11 ’24 to sell 32600.0 shares. Meanwhile, 10% Owner Opaleye Management Inc. sold 36492.0 shares on Sep 09 ’24.
